ProPhase Labs’ Resolution for 2025: Nail Down a ‘Liquidity Event’
The company has lost nearly $36 million since 2023, but its CEO is aggressively pursuing new revenue options
Keeps You Up-to-Date on Lab Business and Competitive Strategy, Market Trends and Opportunities, and M&A and Investment Activity in Today’s Diagnostic Lab Industry
The company has lost nearly $36 million since 2023, but its CEO is aggressively pursuing new revenue options
From - Laboratory Industry Report
Transgenomic has released two new liquid biopsy tests for colorectal cancer and metastatic melanoma…
From - Laboratory Industry Report
Veritas Genetics is launching a whole genome test under the four-figure price point…
From - Laboratory Industry Report
LifeCode Health has been acquired by an Indian company that will use its assets as a foothold into the U.S. market…